NVS NOVELSTAR PHARMACEUTICALS INC. Trademark

Trademark Overview

On Monday, August 15, 2022, a trademark application was filed for NVS NOVELSTAR PHARMACEUTICALS INC. with the United States Patent and Trademark Office. The USPTO has given the NVS NOVELSTAR PHARMACEUTICALS INC. trademark a serial number of 97549234. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 21, 2026. This trademark is owned by Novelstar Pharmaceuticals Inc.. The NVS NOVELSTAR PHARMACEUTICALS INC. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes
nvs novelstar pharmaceuticals inc.

General Information

Serial Number97549234
Word MarkNVS NOVELSTAR PHARMACEUTICALS INC.
Filing DateMonday, August 15, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 2026

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS INC."
Description of MarkThe mark consists of a circle with enclosed stylized text of "NVS", followed by text which reads "NOVELSTAR", under which is set forth a text "PHARMACEUTICALS INC."
Goods and ServicesPharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovelstar Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
US
Party NameNovelstar Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
US

Trademark Events

Event DateEvent Description
Thursday, August 18, 2022NEW APPLICATION ENTERED
Saturday, September 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 6, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 1, 2023ASSIGNED TO EXAMINER
Wednesday, June 14, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 14, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 19, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 19, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, September 19, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 19, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, September 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 10, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 10, 2024SOU EXTENSION 1 FILED
Monday, June 10, 2024SOU EXTENSION 1 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Monday, July 15, 2024ASSIGNED TO PETITION STAFF
Tuesday, July 16, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, July 16, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, July 25, 2024NOTICE OF ALLOWANCE CANCELLED
Thursday, July 25, 2024CASE RETURNED TO EXAMINATION
Monday, November 4, 2024ASSIGNED TO EXAMINER
Monday, November 4, 2024ASSIGNED TO EXAMINER
Tuesday, November 5, 2024ASSIGNED TO EXAMINER
Wednesday, April 2, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, June 10, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 19, 2026ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, July 15, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2026PUBLISHED FOR OPPOSITION
Tuesday, July 21, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

pharmaceuticals novelstar diseases disorders namely preparations pharmaceutical infectious immunological urological allergies hypertension